Courtney Crane

SVP, Research at Mozart Therapeutics

Courtney Crane is the Senior Vice President, Research at Mozart Therapeutics. Previously as an Associate Professor at the University of Washington, she established and mentored a research team that developed novel cell therapy platforms using gene edited natural killer cells and macrophages for the delivery of several classes of soluble proteins, including cytokines, bispecific T cell engagers, and full-length antibodies. During this time, she established several industry sponsored research programs, and successfully out-licensed multiple technologies developed in her lab to a publicly-traded biotech company. Dr. Crane received her Ph.D. in Immunology from the University of Virginia under the mentorship of Dr. Margo Roberts, and completed her postdoctoral research at the University of California, San Francisco studying the dysregulation of immune responses in brain tumors with Drs. Lewis Lanier and Andrew Parsa before starting an independent research program as academic faculty. She is an author on over 30 peer-reviewed publications and patents and continues her role as strategic advisor for public and privately-held biotechnology industry partners.

Location

Issaquah, United States

Links

Previous companies


Org chart


Teams


Offices


Mozart Therapeutics

Mozart Therapeutics is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases. The company is using a novel regulatory CD8 T cell network to create disease-modifying CD8 Treg modulators for a variety of autoimmune diseases. Mozart is developing a pipeline of first-in-class 'CD8Treg modulators with the goal of restoring long-term immune balance and preventing the progressive damage caused by an autoreactive and pathogenic immune response.


Industries

Employees

1-10

Links